Kaizen Financial Strategies »

SPDR S&P Pharmaceuticals shares owned by Kaizen Financial Strategies

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Kaizen Financial Strategies from 13F filings

Historical chart of Kaizen Financial Strategies investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Kaizen Financial Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Kaizen Financial Strategies

Quarter filed Position value Share count Share price at filing
2026-09-30 $228k 3.5k 65.00

More positions owned by Kaizen Financial Strategies

Apple (AAPL)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Capital Group Dividend Value Shs Creat Unit (CGDV)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Fundamental Us B (FNDB)
Schwab Strategic Tr 5 10yr Corp Bd (SCHI)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Vanguard Whitehall Fds High Div Yld (VYM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vaneck Etf Trust Semiconductr Etf (SMH)
Schwab Strategic Tr Fundamental Intl (FNDF)
J P Morgan Exchange Traded F Intrnl Res Eqt (JIRE)

View all positions for Kaizen Financial Strategies

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
Wells Fargo & Company
Envestnet Asset Management
First Citizens Bank & Trust
Envestnet Portfolio Solutions
LPL Financial
Branch Banking & Trust Company
Measured Wealth Private Client Group
Private Advisor
UBS Group
Susquehanna International
Cetera Investment Advisers
Wharton Business Group
Bp Wealth Management
Great Diamond Partners

View all funds holding SPDR S&P Pharmaceuticals